Literature DB >> 9176525

Immunization with a plasmid expressing pneumococcal surface protein A (PspA) can elicit protection against fatal infection with Streptococcus pneumoniae.

L S McDaniel1, F Loechel, C Benedict, T Greenway, D E Briles, R M Conry, D T Curiel.   

Abstract

Pneumococcal surface protein A (PspA) is a protectioneliciting protein of Streptococcus pneumoniae. We observed that immunization of BALB/c mice with a plasmid expressing PspA significantly protected the mice from lethal challenge with S. pneumoniae when compared to control mice that received injections of the plasmid vector alone. The plasmid construct expressing PspA has been designated pKSD2601. Mice immunized intramuscularly with pKSD2601 had a mean log of colony-forming units of 2.67 +/- 0.25 pneumococci circulating in their blood at 24 h after challenge as compared with control mice that had a mean log of colony-forming units of 4.95 +/- 0.59. Those mice with lower numbers of pneumococci subsequently survived the challenge. Given the quantitative nature and ultimate end point (ie live versus dead) our mouse model should be useful in working out optimum expression of bacterial genes for DNA immunization.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9176525     DOI: 10.1038/sj.gt.3300401

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  5 in total

1.  Intranasal vaccination with chitosan-DNA nanoparticles expressing pneumococcal surface antigen a protects mice against nasopharyngeal colonization by Streptococcus pneumoniae.

Authors:  Jianghong Xu; Wenjia Dai; Zhengmin Wang; Bing Chen; Zhongming Li; Xiaoyong Fan
Journal:  Clin Vaccine Immunol       Date:  2010-11-03

2.  Identification of pneumococcal surface protein A as a lactoferrin-binding protein of Streptococcus pneumoniae.

Authors:  S Hammerschmidt; G Bethe; P H Remane; G S Chhatwal
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

3.  Genetic immunization with the region encoding the alpha-helical domain of PspA elicits protective immunity against Streptococcus pneumoniae.

Authors:  J R Bosarge; J M Watt; D O McDaniel; E Swiatlo; L S McDaniel
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

4.  Vaccine-induced human antibodies to PspA augment complement C3 deposition on Streptococcus pneumoniae.

Authors:  Martina M Ochs; William Bartlett; David E Briles; Bryony Hicks; Audra Jurkuvenas; Peggy Lau; Bing Ren; Amanda Millar
Journal:  Microb Pathog       Date:  2007-10-11       Impact factor: 3.738

5.  Extracellular matrix formation enhances the ability of Streptococcus pneumoniae to cause invasive disease.

Authors:  Claudia Trappetti; Abiodun D Ogunniyi; Marco R Oggioni; James C Paton
Journal:  PLoS One       Date:  2011-05-18       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.